NASDAQ:OCEA Ocean Biomedical (OCEA) Stock Price, News & Analysis → Jeff Bezos Just Humiliated Elon Musk (From InvestorPlace) (Ad) Free OCEA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.37▼$1.5550-Day Range N/A52-Week Range N/AVolume315,194 shsAverage Volume290,250 shsMarket Capitalization$48.51 millionP/E RatioN/ADividend YieldN/APrice Target$17.63 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsHeadlinesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsCompetitorsHeadlinesOptions ChainOwnershipShort InterestSocial Media Get Ocean Biomedical alerts: Email Address Ocean Biomedical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,159.3% Upside$17.63 Price TargetShort InterestHealthy7.39% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.82 out of 5 starsMedical Sector397th out of 918 stocksPharmaceutical Preparations Industry178th out of 426 stocks 3.5 Analyst's Opinion Consensus RatingOcean Biomedical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageOcean Biomedical has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted7.39% of the float of Ocean Biomedical has been sold short.Short Interest Ratio / Days to CoverOcean Biomedical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ocean Biomedical has recently decreased by 31.21%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOcean Biomedical does not currently pay a dividend.Dividend GrowthOcean Biomedical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OCEA. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 4 news articles for Ocean Biomedical this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for OCEA on MarketBeat in the last 30 days. This is a decrease of -93% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Ocean Biomedical to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ocean Biomedical insiders have not sold or bought any company stock.Percentage Held by Insiders73.50% of the stock of Ocean Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.55% of the stock of Ocean Biomedical is held by institutions. Previous Next N/A Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsWhy Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>> About Ocean BiomedicalAesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.Read More Ad Behind the MarketsWhy Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>> OCEA Stock News HeadlinesApril 26, 2024 | msn.comHow New England entrepreneurs are creating skincare from lobstersApril 25, 2024 | finance.yahoo.comOcean Biomedical, Inc. (OCEA)April 30, 2024 | Behind the Markets (Ad)Why Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.April 24, 2024 | globenewswire.comOcean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-KApril 18, 2024 | msn.comMeet the 11 global world-changers in the 2024 TED Fellows cohortApril 17, 2024 | msn.comWhat’s polluting the oceans? UC San Diego to lead large study of contaminants’ source, fate and health impactsApril 16, 2024 | newsweek.comAGW-Mental Wellbeing 2024 - Mid-size companiesApril 16, 2024 | msn.comTo Help the Allied War Effort, These Scientists Got Drunk on NitrogenApril 30, 2024 | Behind the Markets (Ad)Why Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.April 15, 2024 | msn.comStocks Rise but Gains Limited by Rising Bond YieldsApril 15, 2024 | msn.comStocks Climb Although Iran-Israeli Tensions Remain HighApril 12, 2024 | finance.yahoo.comApheresis Market Worth $3.9 billion | MarketsandMarkets™April 3, 2024 | msn.comUniversity of Strathclyde And British Council Offer £10,000 Engineering ScholarshipApril 3, 2024 | finance.yahoo.comCough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsightApril 2, 2024 | uk.news.yahoo.com"Space debris" spotted over California skyline after rocket launchMarch 28, 2024 | msn.comRice husk can be used as a promising sustainable packaging materialMarch 28, 2024 | globenewswire.comOcean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASLMarch 20, 2024 | seekingalpha.comOcean Biomedical: Shooting Upward, But Not Somewhere I Want To Be (Rating Upgrade)March 20, 2024 | msn.comFor intermittent fasters, 4 protein-rich meals can help you stay full and energized on the goMarch 20, 2024 | finance.yahoo.comOCEA May 2024 7.500 callMarch 20, 2024 | finance.yahoo.comOCEA May 2024 2.500 putMarch 19, 2024 | msn.comHorseshoe crabs, prized by the biomedical industry for their blood, to get new protections in MassachusettsMarch 15, 2024 | yahoo.comCape Cod Poetry: Have you ever read a poem aloud? If not, you are missing good stuff.March 11, 2024 | msn.comEmpirical Research Partners 'prone to trim' chip stocks in March portfolio strategyMarch 10, 2024 | finance.yahoo.comOCEA Mar 2024 10.000 putMarch 7, 2024 | finance.yahoo.comOCEA Apr 2024 10.000 callMarch 7, 2024 | finance.yahoo.comOCEA Jul 2024 12.500 callSee More Headlines Receive OCEA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ocean Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:OCEA CUSIPN/A CIK1836612 WebN/A Phone646-908-2658FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$17.63 High Stock Price Target$17.63 Low Stock Price Target$17.63 Potential Upside/Downside+1,159.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-960,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-287.36% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($2.26) per share Price / Book-0.62Miscellaneous Outstanding Shares34,650,000Free Float9,182,000Market Cap$48.51 million OptionableOptionable Beta1.28 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key CompetitorsCheckpoint TherapeuticsNASDAQ:CKPTBioLineRxNASDAQ:BLRXCalciMedicaNASDAQ:CALCEledon PharmaceuticalsNASDAQ:ELDNHomology MedicinesNASDAQ:FIXXView All CompetitorsInstitutional OwnershipSimplex Trading LLCBought 3,800 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions OCEA Stock Analysis - Frequently Asked Questions Should I buy or sell Ocean Biomedical stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ocean Biomedical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" OCEA shares. View OCEA analyst ratings or view top-rated stocks. What is Ocean Biomedical's stock price target for 2024? 1 analysts have issued 1 year target prices for Ocean Biomedical's stock. Their OCEA share price targets range from $17.63 to $17.63. On average, they predict the company's stock price to reach $17.63 in the next twelve months. This suggests a possible upside of 1,159.3% from the stock's current price. View analysts price targets for OCEA or view top-rated stocks among Wall Street analysts. Are investors shorting Ocean Biomedical? Ocean Biomedical saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 643,900 shares, a decrease of 31.2% from the March 31st total of 936,000 shares. Based on an average daily trading volume, of 6,600,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 7.4% of the shares of the stock are sold short. View Ocean Biomedical's Short Interest. When did Ocean Biomedical IPO? Ocean Biomedical (OCEA) raised $22 million in an initial public offering on the week of April 18th 2022. The company issued 2,000,000 shares at a price of $10.00-$12.00 per share. Roth Capital Partners and JonesTrading served as the underwriters for the IPO. This page (NASDAQ:OCEA) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
